TP53 and lung carcinoma: Although markedly lower than in the liver, the expression of CPS1 in lung cancers and p53–depleted tumor cell lines can sufficiently alter cellular homeostasis towards the increased de novo biosynthesis of pyrimidine nucleotides via a higher CAD activity [31,32,34].